RUNX2 and acute myeloid leukemia: We simulated the evolution of resistance-acquisition to BETi in the two AML models that we had extensively tested so far: SKNO1 (RUNX1-RUNX1T1-rearranged) and OCI-AML3 (NPM1mut).